Eric Slattery, MD
Otology & Neurotology · Salt Lake City, UTNPI 1316153695
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Medtronic at 30.0% of the total. Reporting peaked in 2023 at $190 and has fallen 77.0% since, to $44 in 2024.
Across 15 payments — averaging $24.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$111
- Cochlear Americas$67
- Med-el Corporation$63
- Acclarent, Inc$54
- Optinose US, Inc.$29
- Kaleo, Inc.$19
- plus $29 from 2 others
Across 2 payments — averaging $2550.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otonomy, Inc.$5K
What the payments were for
- Food & beverage$370100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 3 | $111 |
| Cochlear Americas | 3 | $67 |
| Med-el Corporation | 2 | $63 |
| Acclarent, Inc | 2 | $54 |
| Optinose US, Inc. | 2 | $29 |
| Kaleo, Inc. | 1 | $19 |
| GSK | 1 | $15 |
| Merck | 1 | $14 |
How this compares
Too few otology & neurotology providers in Utahto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ofloxacin | 43 | $1,059 |
| Acetic Acid | 13 | $241 |
| Ibuprofen | 19 | $145 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $87 |
| Cephalexin | 13 | $84 |
Paid to pharmacies, not to this prescriber.
Other otology & neurotology in Salt Lake City
- Richard GurgelSalt Lake City$62K
- Clough SheltonSalt Lake City$17K
- Jumah AhmadSalt Lake City$2K
- David DarleyProvo$779
- Brian PetersonWest Jordan$96
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.